Leveraging our partnership with UCL
UCL (University College London) is a world-leading academic centre for the discovery and clinical development of gene therapies, with a network of affiliated hospitals in London providing some of the best clinical care in the world to patients with rare genetic diseases. As a spin-out of UCL, we have established a strong partnership with the institution, which spans the completion of our non-clinical research activities to the implementation of our clinical trials. UCL’s unparalleled capabilities and access to patients, through its affiliated hospitals, will help us accelerate the development of our programs.